Florent Delbos

664 total citations
19 papers, 243 citations indexed

About

Florent Delbos is a scholar working on Immunology, Transplantation and Hematology. According to data from OpenAlex, Florent Delbos has authored 19 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Transplantation and 7 papers in Hematology. Recurrent topics in Florent Delbos's work include Renal Transplantation Outcomes and Treatments (10 papers), T-cell and B-cell Immunology (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Florent Delbos is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), T-cell and B-cell Immunology (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Florent Delbos collaborates with scholars based in France, Italy and Morocco. Florent Delbos's co-authors include Magali Giral, Sophie Brouard, Richard Danger, Hélène Ansart‐Pirenne, Nicolas Degauque, Philippe Bierling, Gérald Bertrand, Gaëlle Tilly, Laure Croisille and Cécile Kaplan and has published in prestigious journals such as Journal of the American Society of Nephrology, Frontiers in Immunology and American Journal of Transplantation.

In The Last Decade

Florent Delbos

19 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florent Delbos France 10 97 92 78 49 40 19 243
Marie Tamagne France 8 78 0.8× 66 0.7× 125 1.6× 29 0.6× 42 1.1× 15 243
Rolf Anton Klaasen Norway 9 44 0.5× 79 0.9× 26 0.3× 49 1.0× 40 1.0× 21 296
Janghoon Yoon United States 9 168 1.7× 220 2.4× 36 0.5× 155 3.2× 44 1.1× 22 332
Karoline Edtinger Germany 11 193 2.0× 122 1.3× 23 0.3× 121 2.5× 74 1.9× 13 376
Kerry Crisalli United States 6 119 1.2× 199 2.2× 75 1.0× 151 3.1× 40 1.0× 9 337
Melanie Brown United States 6 70 0.7× 43 0.5× 41 0.5× 38 0.8× 13 0.3× 7 158
Jan Schmidtko Germany 9 142 1.5× 39 0.4× 33 0.4× 158 3.2× 33 0.8× 22 371
Dora Ninova United States 8 97 1.0× 198 2.2× 26 0.3× 187 3.8× 22 0.6× 12 345
Sabrina Pengam France 5 134 1.4× 70 0.8× 11 0.1× 47 1.0× 17 0.4× 10 207
Krisztián Kállay Hungary 9 53 0.5× 21 0.2× 44 0.6× 13 0.3× 42 1.1× 27 196

Countries citing papers authored by Florent Delbos

Since Specialization
Citations

This map shows the geographic impact of Florent Delbos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florent Delbos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florent Delbos more than expected).

Fields of papers citing papers by Florent Delbos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florent Delbos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florent Delbos. The network helps show where Florent Delbos may publish in the future.

Co-authorship network of co-authors of Florent Delbos

This figure shows the co-authorship network connecting the top 25 collaborators of Florent Delbos. A scholar is included among the top collaborators of Florent Delbos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florent Delbos. Florent Delbos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Le, Hoa, Nicolas Degauque, Marie Rimbert, et al.. (2023). Kidney allograft rejection is associated with an imbalance of B cells, regulatory T cells and differentiated CD28-CD8+ T cells: analysis of a cohort of 1095 graft biopsies. Frontiers in Immunology. 14. 1151127–1151127. 9 indexed citations
2.
3.
Masset, Christophe, Gabriela Gautier-Vargas, Diego Cantarovich, et al.. (2022). Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation. Kidney International Reports. 7(5). 983–992. 10 indexed citations
4.
Masset, Christophe, Jacques Dantal, Jean‐Paul Soulillou, et al.. (2022). Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients. Frontiers in Immunology. 13. 1021481–1021481. 3 indexed citations
5.
Walencik, Alexandre, et al.. (2021). HLA‐EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities. HLA. 99(2). 79–92. 3 indexed citations
6.
Jacquemont, Lola, Gaëlle Tilly, Richard Danger, et al.. (2020). Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology. 31(4). 876–891. 56 indexed citations
7.
Cantarovich, Diego, Delphine Kervella, Georges Karam, et al.. (2020). Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trial. American Journal of Transplantation. 20(6). 1679–1690. 8 indexed citations
9.
Devilder, Marie‐Claire, Laetitia Gautreau‐Rolland, Florent Delbos, et al.. (2019). Ex vivo evolution of human antibodies by CRISPR-X: from a naive B cell repertoire to affinity matured antibodies. BMC Biotechnology. 19(1). 14–14. 15 indexed citations
11.
Danger, Richard, Mélanie Chesneau, Florent Delbos, et al.. (2019). CXCR5+PD1+ICOS+ Circulating T Follicular Helpers Are Associated With de novo Donor-Specific Antibodies After Renal Transplantation. Frontiers in Immunology. 10. 2071–2071. 26 indexed citations
12.
Garnier, Alice, Florent Delbos, Thierry Guillaume, et al.. (2018). Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide. Bone Marrow Transplantation. 53(8). 1044–1047. 3 indexed citations
13.
Delbos, Florent, et al.. (2017). Caractérisation de l’allo-immunisation anti-HLA et impact clinique en transfusion et en transplantation d’organe. Transfusion Clinique et Biologique. 24(3). 131–137. 1 indexed citations
15.
Delbos, Florent, et al.. (2016). A novel allele HLA‐C*07:445 identified in a French hematopoietic stem cell donor. HLA. 87(5). 403–404. 1 indexed citations
16.
Delbos, Florent, Walid Barhoumi, Ludovic Cabanne, et al.. (2015). Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(2). 292–299. 23 indexed citations
17.
Delbos, Florent, Gérald Bertrand, Laure Croisille, et al.. (2015). Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage. Transfusion. 56(1). 59–66. 34 indexed citations
18.
Loiseau, Philippe M., Valérie Dubois, Valérie Coiteux, et al.. (2014). Impact des anticorps anti-HLA sur le devenir de l’allogreffe de cellules souches hématopoïétiques : un rapport par la SFGM-TC. Pathologie Biologie. 62(4). 226–229. 4 indexed citations
19.
Stoclin, Annabelle, Florent Delbos, Olivier Brugière, et al.. (2012). Transfusion‐related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient. Vox Sanguinis. 104(2). 175–178. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026